Items where authors include "Clarke, EA"

Article

Relph, KA, Russell, CD, Fairfield, CJ et al. (365 more authors) (2022) Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission. Open Forum Infectious Diseases, 9 (5). ofac179.

Dejnirattisai, W, Huo, J, Zhou, D et al. (461 more authors) (2022) SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell, 185 (3). 467-484.e15. ISSN 0092-8674

Sullivan, MK, Lees, JS, Drake, TM et al. (362 more authors) (2022) Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study : a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, 37 (2). pp. 271-284. ISSN 0931-0509

Niemi, MEK, Karjalainen, J, Liao, RG et al. (3763 more authors) (2021) Mapping the human genetic architecture of COVID-19. Nature, 600 (7889). pp. 472-477. ISSN 0028-0836

de Silva, TI orcid.org/0000-0002-6498-9212, Liu, G, Lindsey, BB orcid.org/0000-0003-4227-2592 et al. (1010 more authors) (2021) The impact of viral mutations on recognition by SARS-CoV-2 specific T cells. iScience, 24 (11). 103353. ISSN 2589-0042

Wickenhagen, A, Sugrue, E, Lytras, S et al. (420 more authors) (2021) A prenylated dsRNA sensor protects against severe COVID-19. Science, 374 (6567). eabj3624. ISSN 0036-8075

Russell, CD, Fairfield, CJ, Drake, TM et al. (369 more authors) (2021) Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study : a multicentre, prospective cohort study. The Lancet Microbe, 2 (8). e354-e365.

Drake, TM, Riad, AM, Fairfield, CJ et al. (400 more authors) (2021) Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. The Lancet, 398 (10296). pp. 223-237. ISSN 0140-6736

Docherty, AB, Mulholland, RH, Lone, NI et al. (377 more authors) (2021) Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. The Lancet Respiratory Medicine, 9 (7). pp. 773-785. ISSN 2213-2600

Drake, TM, Fairfield, CJ, Pius, R et al. (359 more authors) (2021) Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. The Lancet Rheumatology, 3 (7). e498-e506. ISSN 2665-9913

Bloom, CI, Drake, TM, Docherty, AB et al. (340 more authors) (2021) Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 : a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. The Lancet Respiratory Medicine, 9 (7). pp. 699-711. ISSN 2213-2600

Leclerc, QJ, Fuller, NM, Keogh, RH et al. (384 more authors) (2021) Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England. BMC Health Services Research, 21. 566. ISSN 1472-6963

Gupta, RK, Harrison, EM, Ho, A et al. (372 more authors) (2021) Development and validation of the ISARIC 4C deterioration model for adults hospitalised with COVID-19: a prospective cohort study. The Lancet Respiratory Medicine, 9 (4). pp. 349-359. ISSN 2213-2600

Drake, TM, Docherty, AB, Harrison, EM et al. (398 more authors) (2020) Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study. American Journal of Respiratory and Critical Care Medicine, 202 (12). pp. 1656-1665. ISSN 1073-449X

Clarke, EA, Watson, P, Freeston, JE orcid.org/0000-0003-0358-338X et al. (3 more authors) (2019) Assessing arthritis in the context of cystic fibrosis. Pediatric Pulmonology, 54 (6). pp. 770-777. ISSN 8755-6863

Proceedings Paper

Clarke, EA, Ibrahim, M, Martin, K et al. (5 more authors) (2018) P130 Immunosuppression in cystic fibrosis: how worried should we be? In: Journal of Cystic Fibrosis 2018;17(3):S95–S96. 41ST European Cystic Fibrosis Society Conference, Belgrade, Serbia, 06-09 Jun 2018. Elsevier , S95-S96.

Clarke, EA, Taylor, J, Horsley, AR et al. (7 more authors) (2018) Musculoskeletal symptoms represent a significant burden for adults with cystic fibrosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2018, 01-03 May 2018, Liverpool, UK. Oxford Academic .